Predictors of in-hospital mortality in patients with ST-segment elevation myocardial infarction undergoing pharmacoinvasive treatment

Clinics

Volumn 68, Issue 12, 2013, Pages 1516-1520

  de Andrade Falcão, Felipe José ^a   Rodrigues Alves, Cláudia Maria ^a   Pereira Barbosa, Adriano Henrique ^a   Caixeta, Adriano ^a   Almeida Sousa, José Marconi ^a   Marcondes Souza, José Augusto ^a   Amaral, Amaury ^b   Wilke, Luiz Carlos ^b   Perez, Fátima Cristina A ^c   Gonç Júnior, Iran ^a   Stefanini, Edson ^a   Carvalho, Antônio Carlos ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Programa Municipal de Prevenção e Controle de Intoxicações   (Brazil)

^c Department of Oral and Maxillofacial Surgery   (Brazil)

Author keywords

Mortality; Myocardial infarction; Pharmacoinvasive therapy

Indexed keywords

FIBRINOLYTIC AGENT; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BRAZIL; CLINICAL TRIAL; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART STROKE VOLUME; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; PHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; STATISTICS; TERTIARY CARE CENTER; TIME; TREATMENT OUTCOME;

AGED; BRAZIL; FEMALE; FIBRINOLYTIC AGENTS; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TERTIARY CARE CENTERS; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84892766702     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2013(12)07     Document Type: Article

References (30)

1. Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569-619.
2. Piegas LS, Feitosa G, Mattos LA, Nicolau JC, Rossi Neto JM, Timerman A, et al. Sociedade Brasileira de Cardiologia. Diretriz da Sociedade Brasileira de Cardiologia sobre Tratamento do Infarto agudo do Miocárdio com Supradesnível do Segmento ST. Arq Bras Cardiol. 2009;93(6 supl.2):e179-e264.
3. O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Jr., Chung MK, de Lemos JA, et al. ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(4):485-510, http://dx.doi.org/10.1016/j.jacc.2012.11.018.
4. Boden WE, Eagle K, Granger CB. Reperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction. A Comprehensive Review of Contemporary Management Options. J Am Coll Cardiol. 2007;50(10):917-29, http://dx.doi.org/10.1016/j.jacc.2007.04.084.
5. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;e574-e651.
6. Linha do Cuidado do Infarto Agudo do Miocárdio na Rede de Atenção às Urgências [Path of Care of Acute Myocardial Infarction in Emergency Care Networks, guidelines developed by The Brazilian Health Secretary]. Available at: http://portal.saude.gov.br/portal/arquivos/pdf/protocolo_sindrome_coronaria.pdf. (Accessed on December 20, 2012).
7. Caluza ACV, Barbosa AH, Gonçalves I, Oliveira CAL, Matos LN, Zeefried C, et al. Rede de Infarto com Supradesnivelamento de ST: Sistematização em 205 Casos Diminui Eventos Clínicos na Rede Pública [ST-Elevation Myocardial Infarction Network: Systematization in 205 Cases Reduces Clinical Events in the Public Health Care System]. Arq Bras Cardiol. 2012;99(5):1040-8, http://dx.doi.org/10.1590/S0066-782X2012005000100.
8. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985;312(14):932-6.
9. van't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation. 1998;97(23):2302-6, http://dx.doi.org/10.1161/01.CIR.97.23.2302.
10. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41, http://dx.doi.org/10.1159/000180580.
11. WHO. Hemoglobin concentrations for the diagnosis of anemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization, 2011 (WHO/NMH/NHD/MNM/11.1). Available at: http://www.who.int/vmnis/indicators/haemoglobin.pdf. (Accessed on December 20, 2012).
12. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163(19):2345-53, http://dx.doi.org/10.1001/archinte.163.19.2345.
13. Gomes Júnior MPM, Falcão FJA, Alves CMR, Sousa JMA, Herrmann JL, Moreno ACC, et al. Complicações Vasculares em Pacientes Submetidos a Intervenção Coronária Percutânea Precoce por Via Femoral após Fibrinólise com Tenecteplase: Registro de 199 Pacientes. Rev Bras Cardiol Invasiva. 2012;20(3):274-81, http://dx.doi.org/10.1590/S2179-83972012000300010.
14. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med. 2009;360(26):2705-18.
15. Bodí V, Rumiz E, Merlos P, Nunez J, López-Lereu MP, Monmeneu JV, et al. One-week and 6-month cardiovascular magnetic resonance outcome of the pharmacoinvasive strategy and primary angioplasty for the reperfusion of ST-segment elevation myocardial infarction. Revista Española de Cardiología. 2011;4(2):111-20, http://dx.doi.org/10.1016/j.recesp.2010.10.008.
16. Danchin N, Coste P, Ferrieres J, Steg PG, Cottin Y, Blanchard D, et al. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation. 2008;118(3):268-76, http://dx.doi.org/10.1161/circulationaha.107.762765.
17. Armstrong P. WEST Steering Committee. A comparison of pharmacologic therapy with/without timely coronary intervention vs primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) Study. Eur Heart J. 2006;27(13):1530-8, http://dx.doi.org/10.1093/eurheartj/ehl088.
18. Lima EC, Nascimento GA, Pena MI, Vasconcelos VSA, Crepaldi RJQ, Rabelo W, et al. Intervenção Coronária Percutânea Eletiva após Fibrinólise: Dados do REMAT (Registro Madre Teresa) [Elective Percutaneous Coronary Intervention after Fibrinolysis: REMAT Data (Madre Teresa Registry)]. Rev Bras Cardiol Invasiva. 2011;19(4):373-8, http://dx.doi.org/10.1590/S2179-83972011000400007.
19. Mattos LA, Sousa AGMR, Pinto IMF, Silva ER, Carneiro JK, Sousa JE, et al. Uma comparação entre a intervenção coronariana percutânea de resgate e primária realizadas no infarto agudo do miocárdio: relato multicêntrico de 9.371 pacientes. Arq Bras Cardiol. 2004;82(5):434-9, http://dx.doi.org/10.1590/S0066-782X2004000500006.
20. Di Mario C, Dudek D, Piscione F, Mielecki W, Savonitto S, Murena E, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomized, multicentre trial. Lancet. 2008;371(9612):559-68, http://dx.doi.org/10.1016/S0140-6736(08)60268-8.
21. Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, et al. Fibrinolysis or primary PCI in ST-Segment elevation myocardial infarction. N Engl J Med. 2013;368(15):1379-87.
22. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical Implications of the No 'Reflow' Phenomenon: A Predictor of Complications and Left Ventricular Remodeling in Reperfused Anterior Wall Myocardial Infarction. Circulation. 1996;93(2):223-8, http://dx.doi.org/10.1161/01.CIR.93.2.223.
23. Henriques JP, Zijlstra L, van't Hof AW, de Boer MJ, Dambrink JH, Gosselink M, et al. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation. 2003;107(16):2115-9, http://dx.doi.org/10.1161/01.CIR.0000065221.06430.ED.
24. Gibson CM, Murphy SA, Morrow DA, Aroesty JM, Gibbons RJ, Gourlay SG, et al. Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. Am Heart J. 2004;148(2):336-40, http://dx.doi.org/10.1016/j.ahj.2003.12.044.
25. Henriques JP, Zijlstra F, van't Hof AW, de Boer MJ, Dambrink JH, Gosselink M, et al. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation. 2003;107(16):2115-9, http://dx.doi.org/10.1161/01.CIR.0000065221.06430.ED.
26. Costantini CO, Stone GW, Mehran R, Aymong E, Grines CL, Cox DA, et al. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. J Am Coll Cardiol. 2004;44(2):305-12, http://dx.doi.org/10.1016/j.jacc.2004.03.058.
27. Di Nucci TP, Pimentel Filho WA, Correia MB, Abdalla Filho R, Bocchi EA, Custodio WB, et al. Correlação entre o Grau de PerfusãoMiocárdica e a Evolução Clínica Tardia de Pacientes Submetidos a Trombólise e Implante de Stent. Rev Bras Cardiol Invas. 2006;14(1):56-62.
28. Bellandi F, Leoncini M, Maioli M, Toso A, Gallopin M, Piero Dabizzi R. Markers of myocardial reperfusion as predictors of left ventricular function recovery in acute myocardial infarction treated with primary angioplasty. Clinical Cardiology. 2004;27(12):683-8, http://dx.doi.org/10.1002/clc.4960271205.
29. Jolly SS, Yusuf S, Cairns J, Niemela K, Xavier D, Widimsky P, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomized, parallel group, multicentre trial. Lancet. 2011;377(9775):1409-20, http://dx.doi.org/10.1016/S0140-6736(11)60404-2.
30. Romagnoli E, Biondi-Zoccai G, Sciahbasi A, Politi L, Rigattieri S, Pendenza G, et al. Radial Versus Femoral Randomized Investigation in ST-Segment Elevation Acute Coronary Syndrome: The RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) Study. J Am Coll Cardiol. 2012;60(24):2481-97, http://dx.doi.org/10.1016/j.jacc.2012.06.017.